Adenocarcinoma of the Pancreas Recruiting Phase 1 / 2 Trials for Niraparib (DB11793)

Also known as: Pancreatic adenocarcinoma / Adenocarcinoma Pancreas / Pancreas, Adenocarcinoma / Pancreas Adenocarcinoma / Adenocarcinoma of Pancreas / Adenocarcinoma, Pancreas

IndicationStatusPhase
DBCOND0029532 (Adenocarcinoma of the Pancreas)Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03404960Niraparib + Ipilimumab or Nivolumab in Progression Free Pancreatic Adenocarcinoma After Platinum-Based ChemotherapyTreatment